Elutia

Elutia Inc. is a medicalbiotech company specializing in the development and commercialization of drugeluting biomatrix products that enhance the compatibility of implanted medical devices and support softtissue reconstruction. Elutias proprietary technology combines biologic scaffolds with controlled local drug delivery typically antibiotics enabli... ng its products to support healing while reducing risks like infection, device migration, or poor tissue integration. Among its offerings are biologic envelopes for implantable electronic devices (e.g., pacemakers and defibrillators) under the name EluPro BioEnvelope, as well as a biologic matrix for softtissue reconstruction, SimpliDerm. Following a strategic rebrand (the company was formerly called Aziyo Biologics), Elutia is now fully focused on advancing its drugeluting biomatrix platform across multiple therapeutic areas, including cardiovascular device support, neurostimulation devices, and reconstructive/softtissue surgery.Read More